P521: TREATMENT OF BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASM IN PEDIATRIC PATIENTS WITH TAGRAXOFUSP, A CD123-TARGETED THERAPY

P521: TREATMENT OF BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASM IN PEDIATRIC PATIENTS WITH TAGRAXOFUSP, A CD123-TARGETED THERAPY

Bibliographic Details
Main Authors:	N. Pemmaraju, B. Cuglievan, J. Lasky, A. Kheradpour, N. Hijiya, A. S. Stein, S. Meshinchi, C. Mullen, E. Angelucci, L. Vinti, T. I. Mughal, A. Pawlowska
Format:	Article
Language:	English
Published:	Wiley 2022-06-01
Series:	HemaSphere
Online Access:	http://journals.lww.com/10.1097/01.HS9.0000844972.31512.dd

Similar Items

Efficacy and manageable safety of tagraxofusp in blastic plasmacytoid dendritic cell neoplasm: a case series of pediatric and adolescent/young adult patients
by: Naveen Pemmaraju, et al.
Published: (2024-02-01)

Tagraxofusp for blastic plasmacytoid dendritic cell neoplasm
by: Marlise R. Luskin, et al.
Published: (2023-03-01)

Treatment of leptomeningeal disease in blastic plasmacytoid dendritic cell neoplasm following tagraxofusp-erzs induction
by: Deepak B. Vangala, et al.
Published: (2022-04-01)

Foot gangrene following Tagraxofusp treatment for blastic plasmacytoid dendritic cell neoplasm: Case report
by: Jad Sibai, et al.
Published: (2022-11-01)

Overcoming Tagraxofusp-Erzs Monotherapy Resistance in Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) in a Real-World Clinical Setting
by: Prajwal Dhakal, et al.
Published: (2024-08-01)

P529: FIRST EUROPEAN REAL-WORLD EVIDENCE PROSPECTIVE REGISTRY OF FIRST-LINE ADULT PATIENTS WITH BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASM TREATED WITH FIRST-IN-CLASS CD123-TARGETED THERAPY TAGRAXOFUSP
by: U. Platzbecker, et al.
Published: (2022-06-01)

P531: AN OBSERVATIONAL, MULTICENTER, RETROSPECTIVE ANALYSIS OF PATIENTS WITH BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASM TREATED WITH TAGRAXOFUSP IN THE EUROPEAN EXPANDED ACCESS PROGRAM
by: M. Herling, et al.
Published: (2022-06-01)

P530: TAGRAXOFUSP IN BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASM WITH/WITHOUT CENTRAL NERVOUS SYSTEM INVOLVEMENT AND INTRATHECAL CHEMOTHERAPY AS PRIMARY TREATMENT OR PROPHYLAXIS: AN ITALIAN EXPERIENCE.
by: G. Rivoli, et al.
Published: (2022-06-01)

PB1902: FIRST EUROPEAN REAL-WORLD EVIDENCE PROSPECTIVE REGISTRY OF TAGRAXOFUSP, A CD123-DIRECTED THERAPY, FOR THE TREATMENT OF FIRST-LINE ADULT PATIENTS WITH BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASM
by: Uwe Platzbecker, et al.
Published: (2023-08-01)

Real-world evidence on tagraxofusp for blastic plasmacytoid dendritic cell neoplasm – collected cases from a single center and case reports
by: Philipp Faustmann, et al.
Published: (2024-04-01)

Blastic plasmacytoid dendritic cell neoplasm: a short review and update
by: Cesare Massone, et al.
Published: (2023-08-01)

Blastic Plasmacytoid Dendritic Cell Neoplasm BPDCN
by: Hanan Hamed
Published: (2023-10-01)

Blastic plasmacytoid dendritic cell neoplasm mimicking dermatomyositis
by: Christopher J. Fay, BA, et al.
Published: (2023-09-01)

Therapeutic Approaches for Blastic Plasmacytoid Dendritic Cell Neoplasm: Allogeneic Hematopoietic Cell Transplantation and Novel Therapies
by: Mohamed A. Kharfan-Dabaja, et al.
Published: (2019-03-01)

Localized skin‐limited blastic plasmacytoid dendritic cell neoplasm
by: Edwin U. Suárez, et al.
Published: (2022-05-01)

Cytoplasmic nucleophosmin is not detected in blastic plasmacytoid dendritic cell neoplasm
by: Fabio Facchetti, et al.
Published: (2009-02-01)

Challenges and practical considerations in the management of blastic plasmacytoid dendritic cell neoplasm: A single-center experience
by: Haripriya Andanamala, et al.
Published: (2024-01-01)

Pediatric Blastic Plasmacytoid Dendritic Cell Neoplasm: A Case Report
by: Jasper X Zheng, et al.
Published: (2024-12-01)

ARID1A mutation in blastic plasmacytoid dendritic cell neoplasm
by: Lei Wang, et al.
Published: (2017-11-01)

An Unusual Manifestation of Blastic Plasmacytoid Dendritic Cell Neoplasm as a Testicular Tumor
by: Daniel M. Pak, et al.
Published: (2019-01-01)

Blastic plasmacytoid dendritic cell neoplasm with leukemic presentation: an Italian multicenter study
by: Livio Pagano, et al.
Published: (2013-02-01)

Bortezomib as a new therapeutic approach for blastic plasmacytoid dendritic cell neoplasm
by: Laure Philippe, et al.
Published: (2017-11-01)

A rare case of Blastic plasmacytoid dendritic cell neoplasm with gynecologic presentation
by: Marzouk Khouloud, et al.
Published: (2024-01-01)

Expounding on the essence of epigenetic and genetic abnormalities in blastic plasmacytoid dendritic cell neoplasms
by: Lhara Lezama, et al.
Published: (2019-04-01)

Blastic plasmacytoid dendritic cell neoplasm in children: diagnostic features and clinical implications
by: Armin G. Jegalian, et al.
Published: (2010-11-01)

Spontaneous Remission of Blastic Plasmacytoid Dendritic Cell Neoplasm: A Case Report
by: Tamara Castaño-Bonilla, et al.
Published: (2024-05-01)

Venetoclax monotherapy as front-line therapy for blastic plasmacytoid dendritic cell neoplasm
by: Ankit Mitesh Shah, et al.
Published: (2023-01-01)

Unmet Clinical Needs and Management Recommendations for Blastic Plasmacytoid Dendritic Cell Neoplasm: A Consensus-based Position Paper From an Ad Hoc International Expert Panel
by: Livio Pagano, et al.
Published: (2023-03-01)

How should we diagnose and treat blastic plasmacytoid dendritic cell neoplasm patients?
by: Francine Garnache-Ottou, et al.
Published: (2019-12-01)

Venetoclax–proteasome inhibitor–dexamethasone for unfit patients with blastic plasmacytoid dendritic cell neoplasm
by: Sabine Khalife-Hachem, et al.
Published: (2025-02-01)

Daratumumab for treatment of blastic plasmacytoid dendritic cell neoplasm. A single-case report
by: Katrine F. Iversen, et al.
Published: (2019-09-01)

Blastic plasmacytoid dendritic cell neoplasm: diagnostic difficulty and proposed flowchart for histopathological diagnosis
by: Gabriel Taylor Castolde, et al.
Published: (2023-08-01)

Dermatoscopic features of blastic plasmacytoid dendritic cell neoplasm: a case report and review of the literature
by: Daniel Argüello-Ruiz, et al.
Published: (2024-10-01)

A Rare Case of Blastic Plasmacytoid Dendritic Cell Neoplasm Occurred in Postchemotherapy of Breast Cancer
by: Jiankun Tong, et al.
Published: (2023-01-01)

A Case of Blastic Plasmacytoid Dendritic Cell Neoplasm Extensively Studied by Flow Cytometry and Immunohistochemistry
by: Martina Pennisi, et al.
Published: (2017-01-01)

A systematic literature review of 74 Chinese blastic plasmacytoid dendritic cell neoplasm patients
by: Chen Gong, et al.
Published: (2024-06-01)

Reduced intensity allogeneic stem cell transplant for treatment of blastic plasmacytoid dendritic cell neoplasm
by: Anand Lokare, et al.
Published: (2014-01-01)

P484: WHOLE EXOME SEQUENCING (WES) CHARACTERIZES THE MUTATIONAL LANDSCAPE OF BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASM (BPDCN)
by: H. Witte, et al.
Published: (2022-06-01)

Immunophenotypic characterization of reactive and neoplastic plasmacytoid dendritic cells permits establishment of a 10-color flow cytometric panel for initial workup and residual disease evaluation of blastic plasmacytoid dendritic cell neoplasm
by: Wei Wang, et al.
Published: (2020-04-01)

Blastic plasmacytoid dendritic cell neoplasm: genomics mark epigenetic dysregulation as a primary therapeutic target
by: Maria Rosaria Sapienza, et al.
Published: (2019-04-01)